These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 18049891

  • 1. NBS1 variant I171V and breast cancer risk.
    Bogdanova N, Schürmann P, Waltes R, Feshchenko S, Zalutsky IV, Bremer M, Dörk T.
    Breast Cancer Res Treat; 2008 Nov; 112(1):75-9. PubMed ID: 18049891
    [Abstract] [Full Text] [Related]

  • 2. I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer.
    Roznowski K, Januszkiewicz-Lewandowska D, Mosor M, Pernak M, Litwiniuk M, Nowak J.
    Breast Cancer Res Treat; 2008 Jul; 110(2):343-8. PubMed ID: 17899368
    [Abstract] [Full Text] [Related]

  • 3. Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumours.
    Nowak J, Mosor M, Ziółkowska I, Wierzbicka M, Pernak-Schwarz M, Przyborska M, Roznowski K, Pławski A, Słomski R, Januszkiewicz D.
    Eur J Cancer; 2008 Mar; 44(4):627-30. PubMed ID: 18280732
    [Abstract] [Full Text] [Related]

  • 4. Germline NBS1 mutations in families with aggregation of Breast and/or ovarian cancer from north-east Poland.
    Kanka C, Brozek I, Skalska B, Siemiatkowska A, Limon J.
    Anticancer Res; 2007 Mar; 27(4C):3015-8. PubMed ID: 17695489
    [Abstract] [Full Text] [Related]

  • 5. Is the NBN gene mutation I171V a potential risk factor for malignant solid tumors in children?
    Nowak J, Mosor M, Nowicka K, Rembowska J, Januszkiewicz D.
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):e248-9. PubMed ID: 21436738
    [Abstract] [Full Text] [Related]

  • 6. Nijmegen Breakage Syndrome mutations and risk of breast cancer.
    Bogdanova N, Feshchenko S, Schürmann P, Waltes R, Wieland B, Hillemanns P, Rogov YI, Dammann O, Bremer M, Karstens JH, Sohn C, Varon R, Dörk T.
    Int J Cancer; 2008 Feb 15; 122(4):802-6. PubMed ID: 17957789
    [Abstract] [Full Text] [Related]

  • 7. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F, Duffy DL, Kay GF, Kedda MA, Spurdle AB, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Australian Ovarian Cancer Study Management Group.
    J Natl Cancer Inst; 2008 Nov 05; 100(21):1519-29. PubMed ID: 18957670
    [Abstract] [Full Text] [Related]

  • 8. Cancer risk of heterozygotes with the NBN founder mutation.
    Seemanová E, Jarolim P, Seeman P, Varon R, Digweed M, Swift M, Sperling K.
    J Natl Cancer Inst; 2007 Dec 19; 99(24):1875-80. PubMed ID: 18073374
    [Abstract] [Full Text] [Related]

  • 9. NBS1 8360G > C polymorphism is associated with breast cancer risk: a meta-analysis.
    Wang Z, Cui D, Lu W.
    Breast Cancer Res Treat; 2010 Sep 19; 123(2):557-61. PubMed ID: 20143155
    [Abstract] [Full Text] [Related]

  • 10. Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.
    Hebbring SJ, Fredriksson H, White KA, Maier C, Ewing C, McDonnell SK, Jacobsen SJ, Cerhan J, Schaid DJ, Ikonen T, Autio V, Tammela TL, Herkommer K, Paiss T, Vogel W, Gielzak M, Sauvageot J, Schleutker J, Cooney KA, Isaacs W, Thibodeau SN.
    Cancer Epidemiol Biomarkers Prev; 2006 May 19; 15(5):935-8. PubMed ID: 16702373
    [Abstract] [Full Text] [Related]

  • 11. Heterozygous germline mutations in NBS1 among Korean patients with high-risk breast cancer negative for BRCA1/2 mutation.
    Kim H, Cho DY, Choi DH, Jung GH, Shin I, Park W, Huh SJ, Kim SW, Park SK, Lee JW, Nam SJ, Lee JE, Gil WH, Kim SW.
    Fam Cancer; 2015 Sep 19; 14(3):365-71. PubMed ID: 25712764
    [Abstract] [Full Text] [Related]

  • 12. Functional variants in NBS1 and cancer risk: evidence from a meta-analysis of 60 publications with 111 individual studies.
    Gao P, Ma N, Li M, Tian QB, Liu DW.
    Mutagenesis; 2013 Nov 19; 28(6):683-97. PubMed ID: 24113799
    [Abstract] [Full Text] [Related]

  • 13. Penetrance analysis of the PALB2 c.1592delT founder mutation.
    Erkko H, Dowty JG, Nikkilä J, Syrjäkoski K, Mannermaa A, Pylkäs K, Southey MC, Holli K, Kallioniemi A, Jukkola-Vuorinen A, Kataja V, Kosma VM, Xia B, Livingston DM, Winqvist R, Hopper JL.
    Clin Cancer Res; 2008 Jul 15; 14(14):4667-71. PubMed ID: 18628482
    [Abstract] [Full Text] [Related]

  • 14. Molecular genetic analysis of NBS1 in German melanoma patients.
    Meyer P, Stapelmann H, Frank B, Varon R, Burwinkel B, Schmitt C, Boettger MB, Klaes R, Sperling K, Hemminki K, Kammerer S.
    Melanoma Res; 2007 Apr 15; 17(2):109-16. PubMed ID: 17496786
    [Abstract] [Full Text] [Related]

  • 15. The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk.
    Frank B, Hemminki K, Wirtenberger M, Bermejo JL, Bugert P, Klaes R, Schmutzler RK, Wappenschmidt B, Bartram CR, Burwinkel B.
    Carcinogenesis; 2005 Mar 15; 26(3):643-7. PubMed ID: 15550452
    [Abstract] [Full Text] [Related]

  • 16. Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population.
    Saxena A, Dhillon VS, Raish M, Asim M, Rehman S, Shukla NK, Deo SV, Ara A, Husain SA.
    Breast Cancer Res Treat; 2009 Jun 15; 115(3):537-43. PubMed ID: 18574688
    [Abstract] [Full Text] [Related]

  • 17. Association of ionizing radiation-induced foci of NBS1 with chromosomal instability and breast cancer susceptibility.
    Someya M, Sakata K, Tauchi H, Matsumoto Y, Nakamura A, Komatsu K, Hareyama M.
    Radiat Res; 2006 Oct 15; 166(4):575-82. PubMed ID: 17007554
    [Abstract] [Full Text] [Related]

  • 18. Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene.
    Ziólkowska I, Mosor M, Wierzbicka M, Rydzanicz M, Pernak-Schwarz M, Nowak J.
    Cancer Sci; 2007 Nov 15; 98(11):1701-5. PubMed ID: 17894553
    [Abstract] [Full Text] [Related]

  • 19. Association of two mutations in the CHEK2 gene with breast cancer.
    Bogdanova N, Enssen-Dubrowinskaja N, Feshchenko S, Lazjuk GI, Rogov YI, Dammann O, Bremer M, Karstens JH, Sohn C, Dörk T.
    Int J Cancer; 2005 Aug 20; 116(2):263-6. PubMed ID: 15810020
    [Abstract] [Full Text] [Related]

  • 20. Mutational inactivation of the nijmegen breakage syndrome gene (NBS1) in glioblastomas is associated with multiple TP53 mutations.
    Watanabe T, Nobusawa S, Lu S, Huang J, Mittelbronn M, Ohgaki H.
    J Neuropathol Exp Neurol; 2009 Feb 20; 68(2):210-5. PubMed ID: 19151620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.